News Releases

News Release

Meridian Bioscience to Present at the Robert W. Baird 2005 Growth Stock Conference

May 10, 2005 at 11:53 AM EDT

CINCINNATI--(BUSINESS WIRE)--May 10, 2005--Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO) today announced that the Company has been invited to present at the Robert W. Baird 2005 Growth Stock Conference on Wednesday, May 11, 2005 at 2:05 p.m. CDT at the Four Seasons Hotel in Chicago. Bill Motto, Chairman and Chief Executive Officer and Jack Kraeutler, President and Chief Operating Officer, are scheduled to present. A question and answer session will follow and some of the information provided during the session may not have been previously disclosed.

Meridian invites investors to listen to management's remarks, over the Internet, on the Company's website at The link to the Conference is on the Investor Relations home page. The archived broadcast will be available for 60 days.

Meridian is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Utilizing a variety of methods, these products provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as gastrointestinal, viral, and respiratory infections. Meridian diagnostic products are used outside of the human body and require little or no special equipment. The Company's products are designed to enhance patient well-being while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal and upper respiratory infections, serology, parasitology and fungal disease diagnosis. In addition, Meridian is a supplier of rare reagents and specialty biologicals along with proteins and other biologicals used by biopharmaceutical companies engaged in research for new drugs and vaccines. The Company markets its products to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices and diagnostics manufacturers in more than 60 countries around the world. The Company's shares are traded through Nasdaq's National Market, symbol VIVO. Meridian's website address is

CONTACT: Meridian Bioscience, Inc.
John A. Kraeutler, 513-271-3700

SOURCE: Meridian Bioscience, Inc.